Page last updated: 2024-09-03

bq 610 and fr 139317

bq 610 has been researched along with fr 139317 in 1 studies

Compound Research Comparison

Studies (bq 610)	Trials (bq 610)	Recent Studies (post-2010) (bq 610)	Studies (fr 139317)	Trials (fr 139317)	Recent Studies (post-2010) (fr 139317)
124	1	3	219	0	8

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukami, T; Ihara, M; Ishikawa, K; Ohwaki, K; Ozaki, S; Towers, P; Yamanaka, R; Yano, M	1

Other Studies

1 other study(ies) available for bq 610 and fr 139317

Article	Year
[3H]BQ-123, a highly specific and reversible radioligand for the endothelin ETA receptor subtype. European journal of pharmacology, 1995, Feb-14, Volume: 274, Issue:1-3 Topics: Amino Acid Sequence; Azepines; Binding, Competitive; Endothelin Receptor Antagonists; Endothelins; Humans; Indoles; Isotope Labeling; Molecular Sequence Data; Neuroblastoma; Oligopeptides; Peptides, Cyclic; Radioligand Assay; Receptor, Endothelin A; Receptors, Endothelin; Structure-Activity Relationship; Tritium; Tumor Cells, Cultured	1995

Article

Year

[3H]BQ-123, a highly specific and reversible radioligand for the endothelin ETA receptor subtype.

European journal of pharmacology, 1995, Feb-14, Volume: 274, Issue:1-3

Topics: Amino Acid Sequence; Azepines; Binding, Competitive; Endothelin Receptor Antagonists; Endothelins; Humans; Indoles; Isotope Labeling; Molecular Sequence Data; Neuroblastoma; Oligopeptides; Peptides, Cyclic; Radioligand Assay; Receptor, Endothelin A; Receptors, Endothelin; Structure-Activity Relationship; Tritium; Tumor Cells, Cultured

1995